等待开盘 04-02 09:30:00 美东时间
-0.460
-3.44%
今日重点评级关注:HC Wainwright & Co.:维持Atossa Therapeutics"买入"评级,目标价从7美元升至25美元;Needham:维持Nkarta"买入"评级,目标价从10美元升至11美元
03-27 10:22
TD Cowen analyst Andrew Kligerman maintains Accelerant Hldgs (NYSE:ARX) with a Buy and lowers the price target from $36 to $30.
03-26 21:35
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
今日重点评级关注:瑞穗:维持RELMADA THERAPEUTICS"跑赢大市"评级,目标价从10美元升至19美元;奥本海默:维持Pelthos Therapeutics"跑赢大市"评级,目标价从60美元升至62美元
03-23 13:53
Accelerant Holdings (NYSE:ARX) reported quarterly earnings of $0.23 per share. The company reported $248.400 million in sales this quarter. This is a 30.26 percent increase over sales of $190.700 million the same period
03-19 04:37
Accelerant Holdings (NYSE: ARX), a data-driven company modernizing the specialty insurance marketplace through the Accelerant Risk Exchange, today announced financial results for the fourth quarter and full year ended
03-19 04:17
An update from Accelerant Holdings Class A ( ($ARX) ) is now available. Acceler...
02-28 05:33
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gainers include AAOI, NGNE, ARLO, PRAA, BYND, BWIN, PSKY, & DELL.
02-28 01:52
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从4.75美元升至5美元;Brookline Capital:维持C4 Therapeutics"买入"评级,目标价从20美元升至30美元
02-24 10:27
Piper Sandler analyst Paul Newsome maintains Accelerant Holdings (NYSE:ARX) with a Overweight and lowers the price target from $18 to $13.
02-23 20:52